Connie Sanchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Connie Sanchez has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Alan Lars Pehrson
Department of Psychology, Montclair State University, Montclair, NJ, United States
3 shared publications Elena Dale
Brintellix Science Team, H. Lundbeck A/S, Ottiliavej 9, DK-2500 Copenhagen, Denmark
2 shared publicationsLigia Westrich
Lundbeck Research, Paramus, NJ, USA
2 shared publicationsA.R. McQuiston
Department of Anatomy and Neurobiology, Virginia Commonwealth University, Richmond, VA, USA
1 shared publicationAicha Abdourahman
Lundbeck Research, Paramus, NJ, USA
1 shared publication- Aoife M. Thornton
Physiology, School of Medicine, National University of Ireland, Galway, Ireland; Galway Neuroscience Centre, National University of Ireland, Galway, Ireland
1 shared publication
Latest Publications
- Open Access
- 1 May 2021
- Published by Elsevier in Neurobiology of Stress
- Vol. 14, 100303
Chronic adolescent stress causes sustained impairment of cognitive flexibility and hippocampal synaptic strength in female rats
- 1 May 2021
- Published by Elsevier in Neurobiology of Stress
- Vol. 14, 100303
Open AccessChronic adolescent stress causes sustained impairment of cognitive flexibility and hippocampal synaptic strength in female rats
- Open Access
- 1 September 2020
- Published by Elsevier in Neuroscience
- Vol. 444, 9-18
Kappa Opioid Receptor-mediated Modulation of Social Responding in Adolescent Rats and in Rats Prenatally Exposed to Valproic Acid
- 1 September 2020
- Published by Elsevier in Neuroscience
- Vol. 444, 9-18
Open AccessKappa Opioid Receptor-mediated Modulation of Social Responding in Adolescent Rats and in Rats Prenatally Exposed to Valproic Acid
- 13 December 2019
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 29, S103-S104
P.125 Samidorphan, an opioid receptor antagonist, mitigates olanzapine-induced metabolic dysfunction in female rats
- 13 December 2019
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 29, S103-S104
P.125 Samidorphan, an opioid receptor antagonist, mitigates olanzapine-induced metabolic dysfunction in female rats
- 28 September 2016
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 31 (3) , 365-376
In vivo and in vitro effects of vortioxetine on molecules associated with neuroplasticity
Neuroplasticity is fundamental for brain functions, abnormal changes of which are associated with mood disorders and cognitive impairment. Neuroplasticity can be affected by neuroactive medications and by aging. Vortioxetine, a multimodal antidepressant, has shown positive effects on cognitive functions in both pre-clinical and clinical studies. In rodent studies, vortioxetine increases glutamate neurotransmission, promotes dendritic branching and spine maturation, and elevates hippocampal expression of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) at the transcript level. The present study aims to assess the effects of vortioxetine on several neuroplasticity-related molecules in different experimental systems. Chronic (1 month) vortioxetine increased Arc/Arg3.1 protein levels in the cortical synaptosomes of young and middle-aged mice. In young mice, this was accompanied by an increase in actin-depolymerizing factor (ADF)/cofilin serine 3 phosphorylation without altering the total ADF/cofilin protein level, and an increase in the GluA1 subunit of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor phosphorylation at serine 845 (S845) without altering serine 831 (S831) GluA1 phosphorylation nor the total GluA1 protein level. Similar effects were detected in cultured rat hippocampal neurons: Acute vortioxetine increased S845 GluA1 phosphorylation without changing S831 GluA1 phosphorylation or the total GluA1 protein level. These changes were accompanied by an increase in α subunit of Ca2+/calmodulin-dependent kinase (CaMKIIα) phosphorylation (at threonine 286) without changing the total CaMKIIα protein level in cultured neurons. In addition, chronic (1 month) vortioxetine, but not fluoxetine, restored the age-associated reduction in Arc/Arg3.1 and c-Fos transcripts in the frontal cortex of middle-aged mice. Taken together, these results demonstrated that vortioxetine modulates molecular targets that are related to neuroplasticity.
- 28 September 2016
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 31 (3) , 365-376
In vivo and in vitro effects of vortioxetine on molecules associated with neuroplasticity
Neuroplasticity is fundamental for brain functions, abnormal changes of which are associated with mood disorders and cognitive impairment. Neuroplasticity can be affected by neuroactive medications and by aging. Vortioxetine, a multimodal antidepressant, has shown positive effects on cognitive functions in both pre-clinical and clinical studies. In rodent studies, vortioxetine increases glutamate neurotransmission, promotes dendritic branching and spine maturation, and elevates hippocampal expression of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) at the transcript level. The present study aims to assess the effects of vortioxetine on several neuroplasticity-related molecules in different experimental systems. Chronic (1 month) vortioxetine increased Arc/Arg3.1 protein levels in the cortical synaptosomes of young and middle-aged mice. In young mice, this was accompanied by an increase in actin-depolymerizing factor (ADF)/cofilin serine 3 phosphorylation without altering the total ADF/cofilin protein level, and an increase in the GluA1 subunit of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor phosphorylation at serine 845 (S845) without altering serine 831 (S831) GluA1 phosphorylation nor the total GluA1 protein level. Similar effects were detected in cultured rat hippocampal neurons: Acute vortioxetine increased S845 GluA1 phosphorylation without changing S831 GluA1 phosphorylation or the total GluA1 protein level. These changes were accompanied by an increase in α subunit of Ca2+/calmodulin-dependent kinase (CaMKIIα) phosphorylation (at threonine 286) without changing the total CaMKIIα protein level in cultured neurons. In addition, chronic (1 month) vortioxetine, but not fluoxetine, restored the age-associated reduction in Arc/Arg3.1 and c-Fos transcripts in the frontal cortex of middle-aged mice. Taken together, these results demonstrated that vortioxetine modulates molecular targets that are related to neuroplasticity.
- 1 September 2016
- Published by Elsevier in European Journal of Pharmacology
- Vol. 786, 29-35
A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex
- 1 September 2016
- Published by Elsevier in European Journal of Pharmacology
- Vol. 786, 29-35
A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex
- Open Access
- 14 July 2015
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 29 (10) , 1092-1105
Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism
Antidepressants often disrupt sleep. Vortioxetine, a multimodal antidepressant acting through serotonin (5-HT) transporter (SERT) inhibition, 5-HT3, 5-HT7and 5-HT1Dreceptor antagonism, 5-HT1Breceptor partial agonism, and 5-HT1Areceptor agonism, had fewer incidences of sleep-related adverse events reported in depressed patients. In the accompanying paper a polysomnographic electroencephalography (sleep-EEG) study of vortioxetine and paroxetine in healthy subjects indicated that at low/intermediate levels of SERT occupancy, vortioxetine affected rapid eye movement (REM) sleep differently than paroxetine. Here we investigated clinically meaningful doses (80–90% SERT occupancy) of vortioxetine and paroxetine on sleep-EEG in rats to further elucidate the serotoninergic receptor mechanisms mediating this difference. Cortical EEG, electromyography (EMG), and locomotion were recorded telemetrically for 10 days, following an acute dose, from rats receiving vortioxetine-infused chow or paroxetine-infused water and respective controls. Sleep stages were manually scored into active wake, quiet wake, and non-REM or REM sleep. Acute paroxetine or vortioxetine delayed REM onset latency (ROL) and decreased REM episodes. After repeated administration, vortioxetine yielded normal sleep-wake rhythms while paroxetine continued to suppress REM. Paroxetine, unlike vortioxetine, increased transitions from non-REM to wake, suggesting fragmented sleep. Next, we investigated the role of 5-HT3receptors in eliciting these differences. The 5-HT3receptor antagonist ondansetron significantly reduced paroxetine’s acute effects on ROL, while the 5-HT3receptor agonist SR57227A significantly increased vortioxetine’s acute effect on ROL. Overall, our data are consistent with the clinical findings that vortioxetine impacts REM sleep differently than paroxetine, and suggests a role for 5-HT3receptor antagonism in mitigating these differences.
- 14 July 2015
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 29 (10) , 1092-1105
Open AccessDifferentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism
Antidepressants often disrupt sleep. Vortioxetine, a multimodal antidepressant acting through serotonin (5-HT) transporter (SERT) inhibition, 5-HT3, 5-HT7and 5-HT1Dreceptor antagonism, 5-HT1Breceptor partial agonism, and 5-HT1Areceptor agonism, had fewer incidences of sleep-related adverse events reported in depressed patients. In the accompanying paper a polysomnographic electroencephalography (sleep-EEG) study of vortioxetine and paroxetine in healthy subjects indicated that at low/intermediate levels of SERT occupancy, vortioxetine affected rapid eye movement (REM) sleep differently than paroxetine. Here we investigated clinically meaningful doses (80–90% SERT occupancy) of vortioxetine and paroxetine on sleep-EEG in rats to further elucidate the serotoninergic receptor mechanisms mediating this difference. Cortical EEG, electromyography (EMG), and locomotion were recorded telemetrically for 10 days, following an acute dose, from rats receiving vortioxetine-infused chow or paroxetine-infused water and respective controls. Sleep stages were manually scored into active wake, quiet wake, and non-REM or REM sleep. Acute paroxetine or vortioxetine delayed REM onset latency (ROL) and decreased REM episodes. After repeated administration, vortioxetine yielded normal sleep-wake rhythms while paroxetine continued to suppress REM. Paroxetine, unlike vortioxetine, increased transitions from non-REM to wake, suggesting fragmented sleep. Next, we investigated the role of 5-HT3receptors in eliciting these differences. The 5-HT3receptor antagonist ondansetron significantly reduced paroxetine’s acute effects on ROL, while the 5-HT3receptor agonist SR57227A significantly increased vortioxetine’s acute effect on ROL. Overall, our data are consistent with the clinical findings that vortioxetine impacts REM sleep differently than paroxetine, and suggests a role for 5-HT3receptor antagonism in mitigating these differences.
- 1 July 2000
- Published by National Academy of Science and Technology, Philippines in Transactions of the National Academy of Science and Technology
- Vol. 22, 131-136
Antagonistic Plants for the Management of the Rice Root-Knot Nematode Meloidogyne graminicola in a Rice-Onion System
A microplant experiment with the following treatments: Tagetes sp., two species of Crotonaria (C. ileana and C. mucronata), rice, and fallow, was conducted to determine the effects of Tagetes and Crotonaria plants on the population and development of the rice root-knot nematode, Meloidogyne graminicola. In the two trials conducted, it was observed that no galls were formed on the roots of Tagetes and Crotonaria plants 60 and 90 days after soil infestation. The rice plants, however, had a root gall count of 305.70 at harvest (90 days). Onion grown on the plots planted previously with Tagetes and Crotonaria did not show root galls. However, galls were observed in onions planted in microplots previously planted with rice. Fresh weight of onions was higher in Tagetes and Crotonaria-treated plots compared to the plots planted with rice and the clean fallow treatments. However, differences were insignificant. This could be due to the nematode control and the added fertility when the biomass of these plants was incorporated into the soil before the onions were planted. Rice planted in these treatments showed significant reduction in the number of galls and nematode density in the soil after 60 days. These results showed that planting Tagetes sp. or Crotonaria spp. in nematode-infested soil is effective and feasible in managing the rice root-knot nematode.
- 1 July 2000
- Published by National Academy of Science and Technology, Philippines in Transactions of the National Academy of Science and Technology
- Vol. 22, 131-136
Antagonistic Plants for the Management of the Rice Root-Knot Nematode Meloidogyne graminicola in a Rice-Onion System
A microplant experiment with the following treatments: Tagetes sp., two species of Crotonaria (C. ileana and C. mucronata), rice, and fallow, was conducted to determine the effects of Tagetes and Crotonaria plants on the population and development of the rice root-knot nematode, Meloidogyne graminicola. In the two trials conducted, it was observed that no galls were formed on the roots of Tagetes and Crotonaria plants 60 and 90 days after soil infestation. The rice plants, however, had a root gall count of 305.70 at harvest (90 days). Onion grown on the plots planted previously with Tagetes and Crotonaria did not show root galls. However, galls were observed in onions planted in microplots previously planted with rice. Fresh weight of onions was higher in Tagetes and Crotonaria-treated plots compared to the plots planted with rice and the clean fallow treatments. However, differences were insignificant. This could be due to the nematode control and the added fertility when the biomass of these plants was incorporated into the soil before the onions were planted. Rice planted in these treatments showed significant reduction in the number of galls and nematode density in the soil after 60 days. These results showed that planting Tagetes sp. or Crotonaria spp. in nematode-infested soil is effective and feasible in managing the rice root-knot nematode.
- 1 September 1995
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 77 (3) , 177-181
Effect of Chronic Diazepam Treatment on Footshock‐Induced Ultrasonic Vocalization in Adult Male Rats
Rats were tested in the footshock‐induced ultrasonic vocalization model of anxiety. The ultrasounds were recorded 1–11 min. after 10 inescapable 0.6 mA footshocks each of 1 sec. duration. Repeated administration of benzodiazepines in the clinic has been reported to be accompanied by development of tolerance and withdrawal anxiety. The present study examined whether the ultrasonic vocalization model could reflect these two side effects. Diazepam 4.6 or 8.8 μmol/kg (1.3 or 2.5 mg/kg, subcutaneously) administered twice a day (8 a.m. and 4 p.m.) abolished the vocalization after acute administration and after 3 weeks of treatment. Hence, no tolerance developed to the anxiolytic effect of diazepam. When the rats were tested 24 and 48 hr after the last doses of diazepam there were no significant differences from the control group, i.e. no apparent withdrawal anxiety. Instead, the control groups developed tolerance to the shock regimen during the chronic experiments. This was examined further by daily testing of a group of naive rats for 13 days. The findings indicated that there is a limitation in number of test sessions before tolerance to the model develops. In conclusion, the results of the present study contribute to the many contradictory and by no mean unequivocally findings in the literature. It indicates that substantial prediction of anxiolytic effects as well as unwanted side effects cannot be made from one single test model.
- 1 September 1995
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 77 (3) , 177-181
Effect of Chronic Diazepam Treatment on Footshock‐Induced Ultrasonic Vocalization in Adult Male Rats
Rats were tested in the footshock‐induced ultrasonic vocalization model of anxiety. The ultrasounds were recorded 1–11 min. after 10 inescapable 0.6 mA footshocks each of 1 sec. duration. Repeated administration of benzodiazepines in the clinic has been reported to be accompanied by development of tolerance and withdrawal anxiety. The present study examined whether the ultrasonic vocalization model could reflect these two side effects. Diazepam 4.6 or 8.8 μmol/kg (1.3 or 2.5 mg/kg, subcutaneously) administered twice a day (8 a.m. and 4 p.m.) abolished the vocalization after acute administration and after 3 weeks of treatment. Hence, no tolerance developed to the anxiolytic effect of diazepam. When the rats were tested 24 and 48 hr after the last doses of diazepam there were no significant differences from the control group, i.e. no apparent withdrawal anxiety. Instead, the control groups developed tolerance to the shock regimen during the chronic experiments. This was examined further by daily testing of a group of naive rats for 13 days. The findings indicated that there is a limitation in number of test sessions before tolerance to the model develops. In conclusion, the results of the present study contribute to the many contradictory and by no mean unequivocally findings in the literature. It indicates that substantial prediction of anxiolytic effects as well as unwanted side effects cannot be made from one single test model.